Clusterin antibody

GeneTex

Clusterin antibody

9

Typically less than 1% cross reactivity against other types of apolipoprotein was detected by ELISA against purified standards. This antibody reacts with human apolipoprotein J and has negligible cross-reactivity with Type A-I, A-II, B, C-I, C-II, C-III a

WB: 1:5000-1:10000. IP: 1:100. ELISA: 1:5000-1:10000. IHC: 1:50-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

ImmunoPrecipitation, Western Blot, ELISA, ImmunoHistoChemistry

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

CLU

clusterin

AAG4; aging-associated protein 4; APOJ; APO-J; apolipoprotein J; CLI; CLU1; CLU2; clusterin; complement cytolysis inhibitor; complement lysis inhibitor; complement-associated protein SP-40,40; epididymis secretory sperm binding protein; ku70-binding protein 1; KUB1; NA1/NA2; SGP2; SGP-2; SP-40; sulfated glycoprotein 2; testosterone-repressed prostate message 2; TRPM2; TRPM-2

Goat

IgG

Clusterin

At least 9 distinct polymorphic forms of apolipoproteins are known. The apolipoproteins act as stabilizers of the intact lipoprotein particles. Quantitative measurements of HDL, LDL and VLDL particles in human serum are often used to estimate an individuals relative risk of coronary heart disease. In addition, quantitative immunological measurements of certain apolipoproteins (especially A-1 and B) have been suggested to be more accurate estimators of coronary heart disease than measurements of lipoprotein particles (especially HDL and LDL). The apolipoproteins are derived from human plasma by density gradient ultracentrifugation and HPLC.

Human

-20°C or -80°C,2°C to 8°C

12352203